Mereo BioPharma Group plc (MPH.L) (LON:MPH – Get Free Report)’s stock price fell 1.9% during trading on Wednesday . The stock traded as low as GBX 26 ($0.32) and last traded at GBX 26.50 ($0.33). 49,264 shares were traded during trading, a decline of 85% from the average session volume of 333,975 shares. The stock had previously closed at GBX 27 ($0.33).
Mereo BioPharma Group plc (MPH.L) Price Performance
The company has a current ratio of 2.98, a quick ratio of 2.92 and a debt-to-equity ratio of 164.26. The stock has a market capitalization of £89.76 million and a price-to-earnings ratio of -0.21. The company’s 50 day moving average is GBX 26.50 and its 200 day moving average is GBX 26.50.
About Mereo BioPharma Group plc (MPH.L)
Mereo BioPharma Group plc, a biopharmaceutical company, acquires, develops, and commercializes therapeutics for the treatment of oncology and rare diseases. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the treatment of tumor.
Featured Stories
- Five stocks we like better than Mereo BioPharma Group plc (MPH.L)
- How to Calculate Inflation Rate
- Williams-Sonoma is a steal for buy-and-hold investors
- Space Investment: How to Invest in Space Exploration
- A closer look at Warren Buffett’s latest surprise purchase
- What is Insider Trading? What You Can Learn from Insider Trading
- GE stock surges to six-year high: What’s behind the move?
Receive News & Ratings for Mereo BioPharma Group plc (MPH.L) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mereo BioPharma Group plc (MPH.L) and related companies with MarketBeat.com's FREE daily email newsletter.
